Table 7. Prognostic factors associated with survival without HBV complications or death in 1074 patients.
Baseline factor | Univariate | Multivariate | ||||
Regression coefficient | 95% CI | P value | Regression coefficient | 95% CI | P value | |
Biomarker liver injury | ||||||
FibroTest | 5.42 | 4.24–6.61 | <0.001 | 5.21 | 3.53–6.88 | <0.001 |
ActiTest | 2.84 | 2.01–3.67 | <0.001 | 0.41 | −1.03–1.84 | 0.581 |
ALT | 0.0003 | −0.0004∶0.001 | 0.49 | −0.001 | −0.003−0.000 | 0.052 |
Host factor | ||||||
Older age | 0.06 | 0.04–0.08 | <0.001 | 0.026 | 0.003–0.048 | 0.026 |
Male gender | 1.41 | 0.49–2.34 | 0.003 | 0.55 | −0.42–1.52 | 0.266 |
Caucasian | 0.75 | 0.20–1.31 | 0.008 | 0.07 | −0.56–0.69 | 0.827 |
Viral related | ||||||
Viral load | 0.57 | 0.26–0.87 | 0.0003 | 0.53 | 0.15–0.92 | 0.007 |
HbeAg | 0.58 | −0.03–1.20 | 0.06 | 0.13 | −0.64–0.88 | 0.746 |
Coinfection HCV, HIV or Delta | 0.45 | −0.24–1.14 | 0.20 | −0.29 | −1.12–0.53 | 0.478 |
Other factor | ||||||
Alcohol consumption > = 50 g/day | 1.78 | 1.08–2.47 | <0.001 | 0.67 | −0.10–1.44 | 0.091 |
Treatment effect | 0.99 | 0.23–0.75 | 0.01 | −0.25 | −1.09–0.59 | 0.563 |